We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Copa Holdings
CPA
$5.49B
| $24M | 0.11% |
216,651
+67,167
| +45% | +$6.73M |
|
|
CTLT
252
DELISTED
CATALENT, INC.
CTLT
| $23.9M | 0.11% |
+552,094
| New | +$24.2M |
|
253
Nutrien
NTR
$32.1B
| $23.9M | 0.11% |
405,393
+393,417
| +3,285% | +$25M |
|
254
Best Buy
BBY
$17.6B
| $23.9M | 0.11% |
+291,796
| New | +$21.8M |
|
|
CNR
255
Core Natural Resources Inc
CNR
$4.65B
| $23.5M | 0.11% |
347,158
-48,625
| -12% | -$2.97M |
|
256
Incyte
INCY
$24.5B
| $23.4M | 0.11% |
+375,793
| New | +$25.1M |
|
257
Semtech
SMTC
$12.2B
| $23.4M | 0.11% |
917,132
+403,943
| +79% | +$8.72M |
|
258
Arrow Electronics
ARW
$10.5B
| $23.3M | 0.11% |
162,651
-19,592
| -11% | -$2.44M |
|
259
Booz Allen Hamilton
BAH
$9.45B
| $23M | 0.11% |
206,082
-186,454
| -47% | -$18.4M |
|
260
Gaming and Leisure Properties
GLPI
$12.4B
| $22.9M | 0.11% |
472,816
-78,901
| -14% | -$3.93M |
|
261
Trimble
TRMB
$13.5B
| $22.6M | 0.11% |
426,704
-150,895
| -26% | -$7.38M |
|
262
Medpace
MEDP
$16.9B
| $22.5M | 0.11% |
93,729
-26,925
| -22% | -$5.59M |
|
263
Dow Inc
DOW
$22.6B
| $22.5M | 0.11% |
422,596
+347,854
| +465% | +$18.5M |
|
264
Church & Dwight Co
CHD
$24.4B
| $22M | 0.1% |
+219,897
| New | +$20.7M |
|
265
Synopsys
SNPS
$78.7B
| $22M | 0.1% |
+50,492
| New | +$20.3M |
|
266
Applovin
APP
$107B
| $21.9M | 0.1% |
+852,360
| New | +$17.6M |
|
267
Mobileye
MBLY
$7.54B
| $21.6M | 0.1% |
+561,180
| New | +$22.8M |
|
268
Tandem Diabetes Care
TNDM
$1.63B
| $21.5M | 0.1% |
877,031
+392,407
| +81% | +$12.6M |
|
269
Expedia Group
EXPE
$38.5B
| $21.4M | 0.1% |
195,736
-51,347
| -21% | -$5.03M |
|
270
Freeport-McMoran
FCX
$96.4B
| $21.3M | 0.1% |
+533,687
| New | +$20.3M |
|
271
Fastly Inc
FSLY
$4.58B
| $21.3M | 0.1% |
1,349,606
-60,700
| -4% | -$930K |
|
|
CFLT
272
DELISTED
Confluent
CFLT
| $21.2M | 0.1% |
+600,127
| New | +$16.8M |
|
273
Brookfield
BN
$110B
| $21.2M | 0.1% |
944,400
-855,921
| -48% | -$18.1M |
|
274
Honeywell
HON
$72.9B
| $21.2M | 0.1% |
108,228
-487,665
| -82% | -$90.6M |
|
275
Wolfspeed
WOLF
$1.57B
| $21.2M | 0.1% |
+380,743
| New | +$19.4M |
|
Similar funds
CS
KK
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.